Supernus Pharmaceuticals reported $41.47M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Abbott USD 3.05B 870M Jun/2025
ANI Pharmaceuticals USD 54.08M 5.72M Jun/2025
Aurora Cannabis CAD -11427000 13.94M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Canopy Growth CAD -21827000 13.2M Jun/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Eisai JPY 8.81B 28.8B Mar/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Novo Nordisk 38.28B 4.34B Jun/2025
Pacira USD 54.32M 24.98M Jun/2025
Perrigo USD 129.1M 1.9M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Supernus Pharmaceuticals USD 41.47M 23.68M Jun/2025
United Therapeutics USD 436.8M 34.2M Jun/2025
Xeris Pharmaceuticals USD 8.59M 2.87M Jun/2025